Eli Lilly and Company (NYSE:LLY) is included in the list of the best performing S&P 500 stocks in the last five years. Robust Demand for Eli Lilly and Company (LLY)’s Obesity and Diabetes Treatments Drives Strong Investor Sentiment As of February 6, 2026, robust demand for the company’s obesity and diabetes treatments continues to drive strong investor sentiment. Eli Lilly and Company (NYSE:LLY)’s shares have gained roughly 70% in the past six months. According to the company’s press release dated Febru ...